HYUNDAI Financial Statements From 2010 to 2024

052260 Stock  KRW 4,275  10.00  0.23%   
HYUNDAI BIOLAND financial statements provide useful quarterly and yearly information to potential HYUNDAI BIOLAND CoLtd investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on HYUNDAI BIOLAND financial statements helps investors assess HYUNDAI BIOLAND's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting HYUNDAI BIOLAND's valuation are summarized below:
HYUNDAI BIOLAND CoLtd does not currently have any fundamental trends for analysis.
Check HYUNDAI BIOLAND financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HYUNDAI BIOLAND's main balance sheet or income statement drivers, such as , as well as many indicators such as . HYUNDAI financial statements analysis is a perfect complement when working with HYUNDAI BIOLAND Valuation or Volatility modules.
  
This module can also supplement various HYUNDAI BIOLAND Technical models . Check out the analysis of HYUNDAI BIOLAND Correlation against competitors.

HYUNDAI BIOLAND CoLtd Company Current Valuation Analysis

HYUNDAI BIOLAND's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current HYUNDAI BIOLAND Current Valuation

    
  347.91 B  
Most of HYUNDAI BIOLAND's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HYUNDAI BIOLAND CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, HYUNDAI BIOLAND CoLtd has a Current Valuation of 347.91 B. This is much higher than that of the Personal Products sector and significantly higher than that of the Consumer Staples industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.

HYUNDAI BIOLAND CoLtd Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining HYUNDAI BIOLAND's current stock value. Our valuation model uses many indicators to compare HYUNDAI BIOLAND value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HYUNDAI BIOLAND competition to find correlations between indicators driving HYUNDAI BIOLAND's intrinsic value. More Info.
HYUNDAI BIOLAND CoLtd is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value HYUNDAI BIOLAND by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for HYUNDAI BIOLAND's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About HYUNDAI BIOLAND Financial Statements

HYUNDAI BIOLAND stakeholders use historical fundamental indicators, such as HYUNDAI BIOLAND's revenue or net income, to determine how well the company is positioned to perform in the future. Although HYUNDAI BIOLAND investors may analyze each financial statement separately, they are all interrelated. For example, changes in HYUNDAI BIOLAND's assets and liabilities are reflected in the revenues and expenses on HYUNDAI BIOLAND's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in HYUNDAI BIOLAND CoLtd. Please read more on our technical analysis and fundamental analysis pages.
,Ltd manufactures and sells raw materials for cosmetics, and food and pharmaceuticals. ,Ltd was founded in 1995 and is based in Cheongju, South Korea. HYUNDAI BIOLAND is traded on Korean Securities Dealers Automated Quotations in South Korea.

Pair Trading with HYUNDAI BIOLAND

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if HYUNDAI BIOLAND position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HYUNDAI BIOLAND will appreciate offsetting losses from the drop in the long position's value.

Moving together with HYUNDAI Stock

  0.79034220 LG DisplayPairCorr
  0.83005380 Hyundai MotorPairCorr
  0.69005385 Hyundai MotorPairCorr
  0.63005387 Hyundai MotorPairCorr
  0.8089970 Adaptive Plasma TechPairCorr

Moving against HYUNDAI Stock

  0.75015760 Korea Electric PowerPairCorr
The ability to find closely correlated positions to HYUNDAI BIOLAND could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HYUNDAI BIOLAND when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HYUNDAI BIOLAND - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HYUNDAI BIOLAND CoLtd to buy it.
The correlation of HYUNDAI BIOLAND is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as HYUNDAI BIOLAND moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if HYUNDAI BIOLAND CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for HYUNDAI BIOLAND can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in HYUNDAI Stock

HYUNDAI BIOLAND financial ratios help investors to determine whether HYUNDAI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HYUNDAI with respect to the benefits of owning HYUNDAI BIOLAND security.